ALL MARKETS
FTSE 100
FTSE 250
AIM MARKET

Valirx.
91 announcements.
Time Date Ticker Company Announcement
17:15 04-11-2025 VAL Valirx
Posting of Circular and Notice of General Meeting
07:00 04-11-2025 VAL Valirx
Result of WRAP Retail Offer
07:17 30-10-2025 VAL Valirx
Fundraising of up to £1,050,000
07:21 30-10-2025 VAL Valirx
WRAP Retail Offer for up to £300,000
07:00 14-10-2025 VAL Valirx
Inaphaea Commercial update
07:00 29-09-2025 VAL Valirx
Half-year Report
07:00 18-09-2025 VAL Valirx
Inaphaea Commercial Update
07:00 01-09-2025 VAL Valirx
Cytolytix Commercial update
07:00 26-08-2025 VAL Valirx
Commercial update
10:51 07-08-2025 VAL Valirx
ValiRx Awarded Grant from Open University
09:53 05-08-2025 VAL Valirx
Update on Evaluation Agreement with Stingray Bio
07:00 04-08-2025 VAL Valirx
Licensing Agreement with Dominion Biotech Ltd
15:48 30-06-2025 VAL Valirx
Result of AGM
07:00 20-06-2025 VAL Valirx
Ambrose Exercise Option on VAL401
10:57 09-06-2025 VAL Valirx
ValiRx Investor Webinar
10:54 06-06-2025 VAL Valirx
Holding(s) in Company
07:00 06-06-2025 VAL Valirx
Final Results & Notice of AGM
07:00 03-06-2025 VAL Valirx
New Evaluation and Material Transfer Agreement
13:25 20-05-2025 VAL Valirx
Holding(s) in Company
07:00 12-05-2025 VAL Valirx
Inaphaea Deal Extension With Dominion
07:00 30-04-2025 VAL Valirx
Commercial Update
07:00 03-04-2025 VAL Valirx
Termination of Letter of Intent with TheoremRx
07:00 27-03-2025 VAL Valirx
Directorate Changes and new Advisory Board
11:07 21-03-2025 VAL Valirx
Director Disclosure Update
07:00 24-02-2025 VAL Valirx
Conclusion of Evaluation Project
07:00 03-02-2025 VAL Valirx
Inaphaea Evaluation and Commercial Use Agreement
07:00 30-01-2025 VAL Valirx
Extension of Evaluation Agreement
07:00 29-01-2025 VAL Valirx
New Evaluation and Option Agreement
11:29 15-01-2025 VAL Valirx
Holding(s) in Company
07:00 14-01-2025 VAL Valirx
Holding(s) in Company
11:37 09-01-2025 VAL Valirx
Holding(s) in Company
11:14 09-01-2025 VAL Valirx
Holding(s) in Company
07:00 08-01-2025 VAL Valirx
Holding(s) in Company
11:45 02-01-2025 VAL Valirx
Holding(s) in Company
13:06 31-12-2024 VAL Valirx
Holding(s) in Company
08:39 31-12-2024 VAL Valirx
Update on proposed sub-license of VAL201
13:30 30-12-2024 VAL Valirx
Result of GM, Issue of Equity, Warrants and TVR
16:45 10-12-2024 VAL Valirx
Broker Offer Results & Director/PDMR Subscription
15:03 10-12-2024 VAL Valirx
Posting of Circular and Notice of General Meeting
07:00 09-12-2024 VAL Valirx
Conditional Fundraising & Launch of Broker Offer
07:00 22-11-2024 VAL Valirx
Inaphaea award of HEIF Funding and PhD sponsorship
07:00 20-11-2024 VAL Valirx
Update on proposed sub-license of VAL401
07:00 19-11-2024 VAL Valirx
Contract Award
07:00 18-11-2024 VAL Valirx
First Sale of New Product Line
07:00 30-10-2024 VAL Valirx
Update on proposed sub-license of VAL201
07:00 18-10-2024 VAL Valirx
Directorate Change
07:00 14-10-2024 VAL Valirx
Investor Webinar
07:00 07-10-2024 VAL Valirx
Inaphaea Co-Marketing Agreement
07:00 27-09-2024 VAL Valirx
Half-year Report
07:00 26-09-2024 VAL Valirx
Conclusion of Evaluation Project
07:00 24-09-2024 VAL Valirx
Inaphaea Co-Marketing Agreement
07:00 18-09-2024 VAL Valirx
Inaphaea Evaluation and Commercial Use Agreement
07:00 16-09-2024 VAL Valirx
Inaphaea Co-Marketing Agreement
07:00 09-09-2024 VAL Valirx
Inaphaea Evaluation and Commercial Use Agreement
07:00 09-09-2024 VAL Valirx
Investor Evening
07:00 27-08-2024 VAL Valirx
Inaphaea Evaluation and Commercial Use Agreement
07:00 12-08-2024 VAL Valirx
Directorate Change
07:00 25-07-2024 VAL Valirx
Directorate Changes
08:51 03-07-2024 VAL Valirx
Proposed Director Appointment
11:33 19-06-2024 VAL Valirx
Directorate Change
07:00 17-06-2024 VAL Valirx
Inaphaea Contract Award
07:00 28-05-2024 VAL Valirx
Investor Webinar
07:00 16-05-2024 VAL Valirx
Further re Final Results
07:00 15-05-2024 VAL Valirx
Final Results and Notice of AGM
07:00 22-04-2024 VAL Valirx
Directorate Changes
07:00 21-03-2024 VAL Valirx
Evaluation Agreement with Imperial College London
07:00 19-03-2024 VAL Valirx
Board Re-structuring and update on requisition
17:47 04-03-2024 VAL Valirx
Shareholder Requisition Notice
07:00 04-03-2024 VAL Valirx
Proposed Appointment of Non-Executive Director
14:00 29-02-2024 VAL Valirx
Proposed Appointment of Non-Executive Director
14:20 13-02-2024 VAL Valirx
Further re Shareholder Requisition Notice
17:06 09-02-2024 VAL Valirx
Shareholder Requisition Notice
07:00 19-01-2024 VAL Valirx
Change of Broker
07:00 18-01-2024 VAL Valirx
Directorate Change
13:48 04-01-2024 VAL Valirx
Result of GM, Issue of Equity
07:00 15-12-2023 VAL Valirx
Posting of Circular, Notice of GM and Ops Review
16:56 13-12-2023 VAL Valirx
Retail Offer
16:49 13-12-2023 VAL Valirx
Conditional Fundraise, Notice of General Meeting
07:00 05-12-2023 VAL Valirx
Agreement to License VAL401 to Ambrose Healthcare
07:00 10-11-2023 VAL Valirx
Evaluation Agreement with StingRay Bio
10:45 06-10-2023 VAL Valirx
Statement re Share Price Movement
07:00 28-09-2023 VAL Valirx
Operational Review
07:00 24-08-2023 VAL Valirx
Half-year Report
07:00 14-08-2023 VAL Valirx
Collaborative Services Agreement
14:15 28-06-2023 VAL Valirx
Result of AGM
07:00 16-06-2023 VAL Valirx
Conclusion of Hokkaido Evaluation Agreement
07:00 14-06-2023 VAL Valirx
Asset Purchase – Imagen Therapeutics
07:00 08-06-2023 VAL Valirx
Update on proposed sub-license of VAL201
07:00 07-06-2023 VAL Valirx
Expanded agreement with University of Barcelona
07:00 05-06-2023 VAL Valirx
Final Results and Notice of AGM
07:00 26-05-2023 VAL Valirx
Notice of Results and Investor Webinar